Adar Poonawalla-led Serum Institute has reportedly initiated talks with global private equity firm TPG to sell a 40% stake in SCHOTT Poonawalla, a leading vaccine maker.
Billionaire Adar Poonawalla-led Serum Institute is all set for a major deal. The company, the world’s largest vaccine manufacturer by doses produced and sold, has reportedly started talks with global private equity firm TPG to sell a 40 percent stake in SCHOTT Poonawalla.
Serum Institute’s Plan?
As per news outlet Moneycontrol and insider sources, Serum Institute and TPG appear to be close to reaching an agreement. The Serum Institute is considering selling a major portion (about 40 percent) of its stake in its joint venture to TPG.
Interestingly, other insiders also affirm this, adding that the Serum Institute plans to hold onto a small portion (10 percent) of their joint venture. This move values SCHOTT Poonawalla at a staggering USD 600+ million. Yet, official word from neither TPG nor Serum Institute has broken the silence about the ongoing procedures. The key point to remember is TPG Capital’s extensive influence within pharmaceuticals and healthcare sectors in India, including notable stakes in organisations such as Manipal Hospitals, Sai Life Sciences, Dr Agarwal Healthcare and Nova IVF.
About the Company
SCHOTT Poonawalla is a leading provider of glass packaging, primarily for the pharma and biotech industries. This business is a balanced partnership, with the Serum Institute of India and SCHOTT Pharma AG & Co., a Germany-based SCHOTT AG division, at the helm. SCHOTT AG stands out for its specialization in the manufacture of glass products.
Serum Institute’s Major Deal With Dharma Productions
Recently, Adar Poonawalla-led company declared that its subsidiary, Seren Productions has acquired 50 percent stake in Karan Johar’s Dharma Productions and Dharmatic Entertainment for Rs 1,000 crore.
About Serum Institute
The Serum Institute of India Pvt. Ltd. Has become the world’s premier vaccine production house, achieving the impressive feat of generating over 1.5 billion doses. Their assortment embraces vaccines for a myriad of conditions like Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella, not to mention Pneumococcal and Covid-19 vaccines. An impressive 65% of children across the globe receive at least one of their vaccination shots from the Serum Institute’s production. Their vaccines enjoy the trust of the World Health Organization based in Geneva and find a place in national immunization plans of nearly 170 countries around. This praise-worthy endeavour of the Serum Institute helps save countless lives worldwide.